BCM
PAHC icon

Bayesian Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bayesian Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,308
Closed -$255K – 416
2025
Q3 		$255K Buy
+6,308
New +$208K 0.05% 414

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bayesian Capital Management's PAHC Position: Q4 2025 in Review

Bayesian Capital Management sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 6,308 shares — an estimated $255K sold.

Bayesian Capital Management first reported a position in PAHC in Q3 2025 and held it in 1 quarter. The position peaked at $255K in Q3 2025. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

  • Bayesian Capital Management reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 6,308 Phibro Animal Health shares in Q4 2025, an estimated $255K.
  • Bayesian Capital Management first reported a position in Phibro Animal Health in Q3 2025 and held it in 1 quarter.
  • Bayesian Capital Management's Phibro Animal Health position peaked at $255K in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.